Clinical Trials Directory

Trials / Completed

CompletedNCT01100333

GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)

Observational Study GONAL-f® Consort

Status
Completed
Phase
Study type
Observational
Enrollment
2,552 (actual)
Sponsor
Merck KGaA, Darmstadt, Germany · Industry
Sex
Female
Age
35 Years
Healthy volunteers
Not accepted

Summary

This non-interventional study (NIS) is planned to examine the consistency of the dose recommended by the doctor for the first stimulation day with the dose recommended by the CONSORT calculator.

Detailed description

Since the introduction of the first recombinant human follicle stimulating hormone (FSH) preparation Gonal-f in the year 1996, a pure drug is available as raw material, which is independent of human urine due to biotechnological methods and consequently can be produced free of contaminating proteins. In accordance with the recommendations of European Medicines Agency (EMEA) in February 1999, on the basis of data from clinical studies, Gonal-f should be regarded as the more effective preparation in comparison to urinary FSH. Serono has developed a dose calculator, the CONSORT calculator, after analyzing the data from clinical studies for Gonal-f. This non-interventional study is planned to examine the consistency of the dose recommended by the doctor for the first stimulation day with the dose recommended by the CONSORT calculator. All subjects, who undergo stimulation with Gonal-f in preparation for a technology of the assisted conception in accordance with the permitted indication, will be included in this non-interventional study. OBJECTIVES Primary Objective: * To examine, how far the dose recommended by the doctor for the first stimulation day varies from the dose recommended by the CONSORT calculator

Conditions

Interventions

TypeNameDescription
DRUGRecombinant human follicle stimulating hormone (r-hFSH)Recombinant hFSH prescribed according to prescriber's judgement

Timeline

Start date
2008-04-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-04-08
Last updated
2014-07-31

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01100333. Inclusion in this directory is not an endorsement.